November 18, 2026
Pfizer Inc. (NYSE: PFE) does not need artificial intelligence to discover its patent cliff. The calendar has that covered. What the drugmaker needs is for newer medicines to grow fast enough to replace sales lost as older drugs face…
Serina Therapeutics, Inc. (NYSE American: SER) is building a potentially compelling clinical and platform-driven story around a familiar biotech proposition: take a medicine with demonstrated utility, improve the way it behaves in the body, and create a product patients may find meaningfully…
In the bustling digital amphitheater of Tribe Public’s latest CEO Presentation, the question of the hour was as sharp as it was timely: “Is the beaten down biotech sector the smartest bet in today’s volatile market?” With a flourish of slides and…
